Radiopharmaceutical patient-ready unit doses from cardinal health 414, LLC:1109813 [26-000010]
Ended Awarded Last action
- Contract number
- 75N90026F00001
- Awardee
-
Cardinal Health 414, LLC UEI CWN9UGL3NCL9 Part of Cardinal Health, Inc.
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $612,500
Award facts
- Contract value 100% obligated
- $612,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20814, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $250,000 | |
| Original award | $362,500 |
About this award
Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. specializing in radiopharmaceutical manufacturing and distribution, received a delivery order award from the National Institutes of Health Clinical Center on October 1, 2022, for patient-ready unit doses of radiopharmaceuticals. The contract, which has no set-aside designation, carries a ceiling value of $612,500 and firm fixed-price pricing structure with performance scheduled through September 30, 2026. Work will be performed at the NIH Clinical Center facility in Bethesda, Maryland. This delivery order represents a task order issued against a broader indefinite delivery vehicle, enabling the federal research institution to procure time-sensitive radiopharmaceutical products essential for diagnostic imaging and therapeutic applications supporting the NIH's clinical and research missions.
As a critical supplier of nuclear medicine and diagnostic imaging products to federal healthcare agencies, Cardinal Health 414 maintains extensive experience fulfilling radiopharmaceutical supply requirements across multiple federal entities. The company specializes in manufacturing and distributing a comprehensive portfolio of radiopharmaceutical products including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, and fluorine-18 fluorodeoxyglucose, along with specialized therapeutic radiopharmaceuticals such as Xofigo for prostate cancer treatment and Lymphoseek for diagnostic imaging. Cardinal Health 414's established track record includes numerous federal contract awards with the Department of Veterans Affairs, Defense Health Agency, and National Institutes of Health, demonstrating the company's capability to meet strict regulatory requirements including Nuclear Regulatory Commission licensing, FDA approval, and Department of Transportation compliance for radioactive materials transport.
Quick answers
Who was awarded contract 75N90026F00001?
75N90026F00001 was awarded to Cardinal Health 414, LLC by NIH Clinical Center (National Institutes of Health) on October 1, 2022.
How much is contract 75N90026F00001 worth?
The government has obligated $612,500 on 75N90026F00001.
Is contract 75N90026F00001 an order under another contract?
Yes. 75N90026F00001 is a delivery order under 75N90023D00003, an indefinite delivery contract.
Was contract 75N90026F00001 competed?
The extent of competition for 75N90026F00001 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award